CellaVision AB (publ)
CLVSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $175,633 | $191,328 | $194,802 | $186,688 |
| % Growth | -8.2% | -1.8% | 4.3% | – |
| Cost of Goods Sold | $54,332 | $61,756 | $57,593 | $57,517 |
| Gross Profit | $121,301 | $129,572 | $137,209 | $129,171 |
| % Margin | 69.1% | 67.7% | 70.4% | 69.2% |
| R&D Expenses | $28,684 | $22,364 | $24,580 | $20,297 |
| G&A Expenses | $20,304 | $24,377 | $22,508 | $22,201 |
| SG&A Expenses | $53,074 | $56,898 | $55,511 | $57,524 |
| Sales & Mktg Exp. | $32,770 | $32,521 | $33,003 | $35,323 |
| Other Operating Expenses | $0 | $0 | -$1 | $0 |
| Operating Expenses | $81,758 | $79,262 | $80,090 | $77,821 |
| Operating Income | $39,543 | $50,310 | $57,119 | $51,350 |
| % Margin | 22.5% | 26.3% | 29.3% | 27.5% |
| Other Income/Exp. Net | -$317 | -$2,315 | -$4,618 | $139 |
| Pre-Tax Income | $39,226 | $47,995 | $52,501 | $51,489 |
| Tax Expense | $7,888 | $10,385 | $10,984 | $10,549 |
| Net Income | $31,338 | $37,610 | $41,517 | $40,940 |
| % Margin | 17.8% | 19.7% | 21.3% | 21.9% |
| EPS | 1.31 | 1.58 | 1.74 | 1.72 |
| % Growth | -17.1% | -9.2% | 1.2% | – |
| EPS Diluted | 1.31 | 1.58 | 1.74 | 1.72 |
| Weighted Avg Shares Out | 23,852 | 23,852 | 23,852 | 23,852 |
| Weighted Avg Shares Out Dil | 23,852 | 23,852 | 23,852 | 23,852 |
| Supplemental Information | – | – | – | – |
| Interest Income | $78 | $1,824 | $610 | $2,877 |
| Interest Expense | $395 | $4,139 | $5,227 | $2,738 |
| Depreciation & Amortization | $0 | $0 | $0 | $9,592 |
| EBITDA | $39,621 | $52,134 | $57,728 | $63,819 |
| % Margin | 22.6% | 27.2% | 29.6% | 34.2% |